Pre-procedural 3DCT Versus Angiography Guided PCI for Ostial Right Coronary Artery Lesions
3DCT-RCA
Pre-procedural 3D Reconstructed Computer Tomography Versus Angiography Guided Percutaneous Coronary Intervention for Ostial Right Coronary Artery Lesions
1 other identifier
interventional
30
1 country
1
Brief Summary
Even with second generation drug eluting stents, rates of target lesion failure (TLF) for aorto-ostial RCA lesions remain high \[3yrs TLF 14.2%\]. Retrospective studies show that stent underexpansion and geographical stent-ostium mismatch are the main predictors for TLF. Geographical mismatch means that the stent is implanted either too distal (thereby not fully covering the lesion) or too proximal (thereby protruding too much in the aorta and hampering future engagement with guiding catheters). The investigators hypothesize that, pre-procedural 3D CT coronarography to determine the optimal C-arm angle of the X-ray system with the most accurate visualization of the aorto-ostial angle and determination of localization of calcium, could prevent geographical mismatch.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable coronary-artery-disease
Started Jan 2022
Shorter than P25 for not_applicable coronary-artery-disease
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 24, 2021
CompletedFirst Posted
Study publicly available on registry
December 29, 2021
CompletedStudy Start
First participant enrolled
January 13, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 8, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
February 8, 2023
CompletedMarch 29, 2023
March 1, 2023
1.1 years
November 24, 2021
March 27, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Geographical mismatch as quantified by intra-coronary ultrasound (IVUS)
Distance between the aorta-ostial junction and the most proximal protruding stent strut (in mm).
Procedural
Secondary Outcomes (11)
Geographical mismatch as quantified by intra-coronary ultrasound (IVUS)
Procedural
Geographical mismatch as quantified by intra-coronary ultrasound (IVUS)
Procedural
Volume of contrast agent administered
Procedural
Procedural radiation dose
Procedural
Procedural duration from first puncture of artery to skin closure
Procedural
- +6 more secondary outcomes
Study Arms (2)
3DCT-guided group
EXPERIMENTALPCI guided with 3DCT results and IVUS
Angiography-guided group
PLACEBO COMPARATORPCI guided by operator and IVUS
Interventions
A contrast CT-scan of the coronary arteries will be performed and 3D analyzed to determine the best angle for the C-arm during Percutaneous Coronary Intervention (PCI) for stent implantation. Furthermore determining the amount and localization of calcium in the right coronary artery (RCA) and diameter and length of RCA. The use of IVUS will be used to determine the degree of calcium.
Standard of care is angiography guided PCI of the ostium of the RCA. The use of IVUS will be used to determine the degree of calcium.
Eligibility Criteria
You may qualify if:
- Clinically indicated non-emergent PCI for an aorta-ostial-RCA lesion defined as a significant de novo lesion \[by angiography or by physiological assessment\] for which the operator intends to fully cover the ostial RCA with stent struts
- Willing to provide informed consent
You may not qualify if:
- Emergent PCI indication: if the ostial RCA lesion is the culprit lesion of an acute coronary syndrome \[of note: if the ostial RCA lesion is a non-culprit lesion, patient can be included in the trial\]
- In-stent restenosis or thrombosis in the ostial RCA
- Renal insufficiency \[eGFR\<30 ml/min\]
- Known allergic reaction to contrast medium
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ziekenhuis Oost-Limburg
Genk, Limburg, 3600, Belgium
Related Publications (2)
Mitomo S, Jabbour RJ, Watanabe Y, Mangieri A, Ancona M, Regazzoli D, Tanaka A, Nakajima A, Naganuma T, Giannini F, Latib A, Nakamura S, Colombo A. Comparison of mid-term clinical outcomes after treatment of ostial right coronary artery lesions with early and new generation drug-eluting stents: Insights from an international multicenter registry. Int J Cardiol. 2018 Mar 1;254:53-58. doi: 10.1016/j.ijcard.2017.10.066. Epub 2018 Jan 28.
PMID: 29407132BACKGROUNDvan den Buijs DMF, Poels EM, Willems E, Cottens D, Dotremont K, De Leener K, Meekers E, Ferdinande B, Vrolix M, Dens J, Ameloot K. Three-Dimensional CT for Preprocedural Planning of PCI for Ostial Right Coronary Artery Lesions: A Randomized Controlled Pilot Trial. Circ Cardiovasc Interv. 2025 Feb;18(2):e013584. doi: 10.1161/CIRCINTERVENTIONS.123.013584. Epub 2025 Jan 29.
PMID: 39878016DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Koen Ameloot, Dr.
Ziekenhuis Oost-Limburg
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- The assessor of the IVUS images will be blinded to treatment arm
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Interventional cardiologist
Study Record Dates
First Submitted
November 24, 2021
First Posted
December 29, 2021
Study Start
January 13, 2022
Primary Completion
February 8, 2023
Study Completion
February 8, 2023
Last Updated
March 29, 2023
Record last verified: 2023-03